The information provided in this web site is intended to educate the reader about certain medical conditions and certain possible treatments. It is not a substitute for examination, diagnosis, and medical care provided by a licensed and qualified health professional. If you believe you, suffer from the conditions described herein, please see your health care provider. Do not attempt to treat yourself or anyone else without proper medical supervision.
Read the Full Disclaimer
Exclusión de Responsabilidad - Viñetas
Specific Drugs
TRO19622 olesoxime
TRO19622 olesoxime is an investigational drug that has not yet received any marketing approval from a regulatory agency in any indication – disease or other condition.
In order to gain approval for drugs, it is necessary to prove that the drug is safe to take, as well as providing benefits to the sufferers using the drugs.
TRO19622 olesoxime is therefore going through a process of clinical trials to test safety and the benefits received. In scientific terms, there needs to be efficacy data in man for the treatment of ALS, and the trial needs to demonstrate benefits to ALS sufferers taking TRO19622 olesoxime.
Both for legal and safety reasons, as well as for the trial itself, it is not possible to distribute the drugs outside of the strict medical supervision that will be applied to each patient enrolled in the MitoTarget clinical trial, until the clinical trial processes are completed, and the drug has been approved by regulatory bodies.
